Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12051
CALL
XBiotech
XBIT
$68.6M
| $44K | ﹤0.01% |
+18,400
| New | +$45.4K |
|
12052
Revelation Biosciences
REVB
$4.46M
| $43.8K | ﹤0.01% |
+13,682
| New | +$59.9K |
|
12053
Aprea Therapeutics
APRE
$7.55M
| $43.5K | ﹤0.01% |
+51,041
| New | +$62.7K |
|
|
YYGH
12054
YY Group Holding Ltd
YYGH
$3.78M
| $43.5K | ﹤0.01% |
+144
| New | +$60.2K |
|
|
IH
12055
iHuman
IH
$65.9M
| $43.5K | ﹤0.01% |
20,714
+4,556
| +28% | +$12.1K |
|
12056
CALL
Equillium
EQ
$143M
| $43.4K | ﹤0.01% |
28,000
+10,000
| +56% | +$12.2K |
|
12057
CALL
Acacia Research
ACTG
$440M
| $43.4K | ﹤0.01% |
+11,600
| New | +$41.6K |
|
|
LIMN
12058
Liminatus Pharma
LIMN
$7.13M
| $43.3K | ﹤0.01% |
+70,930
| New | +$78.8K |
|
12059
Good Times Restaurants
GTIM
$15M
| $43.1K | ﹤0.01% |
+35,650
| New | +$49.9K |
|
12060
Identive
INVE
$62.9M
| $43.1K | ﹤0.01% |
11,231
-28,473
| -72% | -$103K |
|
12061
PUT
NetSol Technologies
NTWK
$50.6M
| $43K | ﹤0.01% |
+14,200
| New | +$51.9K |
|
|
12062
PUT
Acacia Research
ACTG
$440M
| $43K | ﹤0.01% |
+11,500
| New | +$41.3K |
|
12063
CPI Aerostructures
CVU
$66M
| $42.9K | ﹤0.01% |
+10,828
| New | +$29.6K |
|
12064
VolitionRx Ltd
VNRX
$8.91M
| $42.9K | ﹤0.01% |
8,387
-8,089
| -49% | -$61.4K |
|
12065
CALL
ADC Therapeutics
ADCT
$140M
| $42.7K | ﹤0.01% |
+12,100
| New | +$49.1K |
|
|
RPTX
12066
CALL
DELISTED
Repare Therapeutics
RPTX
| $42.6K | ﹤0.01% |
+16,400
| New | +$33K |
|
|
ASNS
12067
DELISTED
ACTELIS NETWORKS INC
ASNS
| $42.6K | ﹤0.01% |
+86,186
| New | +$319K |
|
12068
Oxbridge Re Holdings
OXBR
$12.2M
| $42.6K | ﹤0.01% |
+31,778
| New | +$47K |
|
12069
PUT
SkinHealth Systems
SKIN
$91.3M
| $42.4K | ﹤0.01% |
30,500
+4,800
| +19% | +$6.94K |
|
12070
PUT
Magnachip Semiconductor
MX
$133M
| $42.3K | ﹤0.01% |
16,600
+4,700
| +39% | +$13.1K |
|
12071
Network-1 Technologies
NTIP
$36.8M
| $42.3K | ﹤0.01% |
32,287
+9,836
| +44% | +$14.3K |
|
12072
PUT
Ardagh Metal Packaging
AMBP
$3.04B
| $42.2K | ﹤0.01% |
10,300
-62,300
| -86% | -$236K |
|
|
GURE
12073
Gulf Resources
GURE
$4.68M
| $42.1K | ﹤0.01% |
11,391
+97
| +0.9% | +$487 |
|
|
OLPX
12074
CALL
DELISTED
Olaplex Holdings
OLPX
| $42.1K | ﹤0.01% |
31,400
+4,100
| +15% | +$4.88K |
|
12075
Milestone Scientific
MLSS
$39.7M
| $42K | ﹤0.01% |
+153,775
| New | +$58.5K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.